Bridgeway Capital Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,141
| Closed | -$12.3K | – | 1376 |
|
|
2023
Q4 | $12.3K | Hold |
1,141
| – | – | ﹤0.01% | 1349 |
|
|
2023
Q3 | $15.4K | Hold |
1,141
| – | – | ﹤0.01% | 1348 |
|
|
2023
Q2 | $28.5K | Hold |
1,141
| – | – | ﹤0.01% | 1354 |
|
|
2023
Q1 | $19.9K | Hold |
1,141
| – | – | ﹤0.01% | 1356 |
|
|
2022
Q4 | $13K | Hold |
1,141
| – | – | ﹤0.01% | 1355 |
|
|
2022
Q3 | $28K | Buy |
+1,141
| New | +$28K | ﹤0.01% | 1379 |
|
|
2022
Q1 | – | Sell |
-297
| Closed | -$20K | – | 1355 |
|
|
2021
Q4 | $20K | Hold |
297
| – | – | ﹤0.01% | 1254 |
|
|
2021
Q3 | $34K | Hold |
297
| – | – | ﹤0.01% | 1278 |
|
|
2021
Q2 | $45K | Sell |
297
-140
| -32% | -$21.2K | ﹤0.01% | 1320 |
|
|
2021
Q1 | $75K | Hold |
437
| – | – | ﹤0.01% | 1339 |
|
|
2020
Q4 | $42K | Hold |
437
| – | – | ﹤0.01% | 1295 |
|
|
2020
Q3 | $52K | Hold |
437
| – | – | ﹤0.01% | 1297 |
|
|
2020
Q2 | $56K | Buy |
+437
| New | +$56K | ﹤0.01% | 1272 |
|
|
2017
Q2 | – | Sell |
-41
| Closed | -$228K | – | 1472 |
|
|
2017
Q1 | $228K | Sell |
41
-9
| -18% | -$50K | ﹤0.01% | 1251 |
|
|
2016
Q4 | $336K | Sell |
50
-1
| -2% | -$6.72K | ﹤0.01% | 1205 |
|
|
2016
Q3 | $769K | Sell |
51
-15
| -23% | -$226K | 0.01% | 907 |
|
|
2016
Q2 | $1.05M | Hold |
66
| – | – | 0.02% | 763 |
|
|
2016
Q1 | $1.37M | Buy |
66
+40
| +154% | +$831K | 0.02% | 638 |
|
|
2015
Q4 | $520K | Hold |
26
| – | – | 0.01% | 1044 |
|
|
2015
Q3 | $516K | Buy |
26
+20
| +333% | +$397K | 0.01% | 1010 |
|
|
2015
Q2 | $143K | Buy |
+6
| New | +$143K | ﹤0.01% | 1399 |
|
|
2014
Q4 | – | Sell |
-5
| Closed | -$71K | – | 1508 |
|
|
2014
Q3 | $71K | Hold |
5
| – | – | ﹤0.01% | 1445 |
|
|
2014
Q2 | $69K | Hold |
5
| – | – | ﹤0.01% | 1413 |
|
|
2014
Q1 | $103K | Hold |
5
| – | – | ﹤0.01% | 1383 |
|
|
2013
Q4 | $61K | Sell |
5
-4
| -44% | -$48.8K | ﹤0.01% | 1373 |
|
|
2013
Q3 | $134K | Hold |
9
| – | – | ﹤0.01% | 1355 |
|
|
2013
Q2 | $138K | Buy |
+9
| New | +$138K | 0.01% | 1322 |
|